Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. - Wikidata - awgldk - TriplyDB

Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells.

Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells.

http://www.wikidata.org/entity/Q39631963

about

Collective cell migration in development EphA receptor signaling--complexity and emerging themes Ephrin-Eph signaling in embryonic tissue separation Tumor cell migration in complex microenvironments Protein interacting with C kinase 1 suppresses invasion and anchorage-independent growth of astrocytic tumor cells Myosin 1b functions as an effector of EphB signaling to control cell repulsion Variable combinations of specific ephrin ligand/Eph receptor pairs control embryonic tissue separation Directional collective cell migration emerges as a property of cell interactions Contact inhibition of locomotion determines cell-cell and cell-substrate forces in tissues Cadherin-11 mediates contact inhibition of locomotion during Xenopus neural crest cell migration A role for PP1/NIPP1 in steering migration of human cancer cells Structurally encoded intraclass differences in EphA clusters drive distinct cell responses Integrins in the Spotlight of Cancer Protein kinase A can block EphA2 receptor-mediated cell repulsion by increasing EphA2 S897 phosphorylation Inter-Cellular Forces Orchestrate Contact Inhibition of Locomotion Forcing contact inhibition of locomotion Microtubule remodelling is required for the front-rear polarity switch during contact inhibition of locomotion Contact repulsion controls the dispersion and final distribution of Cajal-Retzius cells.EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion.Contact inhibition of locomotion probabilities drive solitary versus collective cell migration.Interplay between chemotaxis and contact inhibition of locomotion determines exploratory cell migration Dynamic interactions between cancer cells and the embryonic microenvironment regulate cell invasion and reveal EphB6 as a metastasis suppressor.Phosphorylation of Rab-coupling protein by LMTK3 controls Rab14-dependent EphA2 trafficking to promote cell:cell repulsion.Front-Rear Polarization by Mechanical Cues: From Single Cells to Tissues.The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo.Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands Design, synthesis and biological evaluation of novel bromophenol derivatives incorporating indolin-2-one moiety as potential anticancer agents.Eph receptors and ephrins as targets for cancer therapy.A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of integrin-β8 in prostate cancer cells.The Cell Adhesion Molecule Necl-4/CADM4 Serves as a Novel Regulator for Contact Inhibition of Cell Movement and Proliferation.Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors Molecular mechanisms of cell segregation and boundary formation in development and tumorigenesis.The role of EphB4 and IGF-IR expression in breast cancer cells Cadherin Switch during EMT in Neural Crest Cells Leads to Contact Inhibition of Locomotion via Repolarization of Forces Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion.Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells.Profiling Eph receptor expression in cells and tissues: a targeted mass spectrometry approach The multifaceted roles of Eph/ephrin signaling in breast cancer.

P2860

Q26771268-01B123EB-248A-4312-BD7E-72236DD1613E Q26864082-3E5B00BC-14EF-4718-A840-27A8890AA1CC Q27021317-AA74CFDC-1725-425B-837F-F0C4ACB5CE4C Q27027489-93AED60A-7163-4246-BF1F-308EBADD9EAB Q27305818-B49BD7F6-2437-46C5-A2B2-D9EA520CB138 Q27310298-D80A2CF0-C69B-4F0E-A912-6DCCD12DE9EA Q27314495-AC242192-8CA3-4E31-A66C-A4FAEC59D2B8 Q27315012-6721F569-EE3B-4653-A8DD-7A595B33A400 Q27316882-75ACC270-DB3E-4666-B3A8-06533C714660 Q27333540-87977E5C-9B42-4734-BDA5-784FB3572D0A Q27334105-519CFDDF-FCEE-4A89-944E-FD184C3D8D89 Q27678839-9D619160-8ECA-45C0-B31B-C687E3E7CD06 Q28066805-E524D089-E4DE-48FF-A1E8-66730AFA9770 Q28116202-135D93E6-EE4B-43AD-8073-01ED46F332DE Q28972395-44687337-010D-48D8-960B-7399BE426CDC Q28972581-81D977E5-B8EC-430F-82CD-BBA150CDBF3A Q30502586-44D942AE-D0C5-45C7-B9D2-4DB87E609AD4 Q30535342-C76A2996-52CF-4690-84DF-91F2C0C37B15 Q30539320-3E0567BC-DCA5-4601-8161-ADD71708BC17 Q30547509-FA4EEF04-9334-4418-B430-02A96BC20C08 Q30637840-AB18E312-E2A7-4A6A-B8BD-743ED159EA36 Q30657415-F5CC5ED6-83B0-4DB1-B468-36313A8E3EA4 Q30842168-FDF7CE4D-2779-408A-AF0C-CAF70EEF237E Q33647687-26CC7065-3676-420D-99A8-77851F7A19E5 Q34078717-6D6BE164-7A93-422E-929C-E87A71231458 Q34390813-36277A91-520D-41BF-9350-54B5B5CAEAE8 Q35069345-E62ACC11-0648-432B-8677-7EC84F63E217 Q35131471-4DD617B8-F840-4DFA-8372-0D6D93F3DAE5 Q35370195-A382F377-1D50-4F2A-B56B-FE5A93491364 Q35385982-53CB33BB-D120-4B71-B00D-AB73BDCCAE0F Q35606620-82E73C31-C463-44A7-AA20-E353FD8812F3 Q35609836-485735DC-FA24-4499-B325-B89DFF575E1A Q35621005-7A551885-700E-479A-A596-2F8067A71445 Q35645904-C04A6D9A-9326-4197-85A3-E314077308B4 Q35854509-6F95CA82-D461-4C76-A32B-7D9FC68C8058 Q36004847-8539D344-502C-4B5D-AD4B-A8BA7014ECA6 Q36223133-B68E9272-EC77-4767-B779-BF78EF45DF3B Q36385691-EADC071D-3381-4102-898D-398F265FC10C Q36402707-1128E60B-1DE7-46F0-8959-DAA241E2E146 Q36402719-C418C757-264B-442C-A350-C66E6B6518BF

P2860

Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells.

http://www.wikidata.org/entity/Q39631963

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Competition amongst Eph recept ...... ness in prostate cancer cells.

@en

Competition amongst Eph recept ...... ness in prostate cancer cells.

@nl

type

label

Competition amongst Eph recept ...... ness in prostate cancer cells.

@en

Competition amongst Eph recept ...... ness in prostate cancer cells.

@nl

prefLabel

Competition amongst Eph recept ...... ness in prostate cancer cells.

@en

Competition amongst Eph recept ...... ness in prostate cancer cells.

@nl

P1433

Q39631963-591F86DB-4702-414F-B769-46CA23F32DBF

P1476

Q39631963-A16B584F-1DFC-480A-B1BE-0A35FDC78841

P2093

Q39631963-51DC0FD3-E83A-4F83-83CD-7E617A2C5669

Q39631963-70201A00-B1F2-43AA-A9F9-DE09491721A2

Q39631963-A9F1D123-BD46-4F09-839B-CBD7D8FCECB1

Q39631963-CCBABE0D-2C0A-4EFD-8AA0-6D191CBC3618

Q39631963-D273FB3F-B4DC-48BE-A0A5-FF9251B76C51

Q39631963-E0383770-46A7-40EF-9A97-FCE689987C65

Q39631963-FA82B425-BA15-4340-B9FA-D9AC6611C915

Q39631963-FBF718C4-5ABE-4FD3-AD64-2F1FDDDDEDB9

P2888

Q39631963-E05BBC4C-9EEC-44F7-8914-7ED7A11507FE

P304

Q39631963-EF150876-1D02-463E-A501-D368B8581D73

P31

Q39631963-D1FB549D-243F-435E-AA3C-88A3E87EE866

P356

Q39631963-D90546E1-281D-44D9-98F9-F0C2A706C4D6

P433

Q39631963-5FCCDBA4-3BEC-413E-BE20-F82A36032228

P478

Q39631963-8E044C55-CEE3-48A0-BEBF-595ED83A31AF

P577

Q39631963-A06F6B9D-232D-48F9-9951-8408C95D3AEC

P6179

Q39631963-9E792272-4A7F-4EF4-857E-B2BE50B15CB2

P698

Q39631963-4C9ED44E-91E2-4265-B7B9-44A746555BE6

P356

P1433

Nature Cell Biology

P1476

Competition amongst Eph recept ...... ness in prostate cancer cells.

@en

P2093

Catherine D Nobes

http://www.w3.org/2001/XMLSchema#string

David Gillatt

http://www.w3.org/2001/XMLSchema#string

Jennifer Batson

http://www.w3.org/2001/XMLSchema#string

Jessica Charlet

http://www.w3.org/2001/XMLSchema#string

Jon D Oxley

http://www.w3.org/2001/XMLSchema#string

Jonathan W Astin

http://www.w3.org/2001/XMLSchema#string

Raj A Persad

http://www.w3.org/2001/XMLSchema#string

Shereen Kadir

http://www.w3.org/2001/XMLSchema#string

P2888

P304

1194-1204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCB2122

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1008430021

http://www.w3.org/2001/XMLSchema#string

P698

21076414

http://www.w3.org/2001/XMLSchema#string